Results 231 to 240 of about 176,852 (287)
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Charbel Skayem +7 more
wiley +1 more source
Programmed cell death receptor 1 inhibitors combined with paclitaxel-platinum induction chemotherapy for treating patients with locally advanced nasopharyngeal carcinoma: a real-world retrospective study. [PDF]
Chen L +5 more
europepmc +1 more source
New insights into the treatment of nasopharyngeal carcinoma in children, adolescents, and young adults: a retrospective study. [PDF]
Ren M +9 more
europepmc +1 more source
The ubiquitin-proteasome system is an important driver of EBV-associated nasopharyngeal carcinoma progression: a meta-analysis of transcriptomic data. [PDF]
Ratnawati H +4 more
europepmc +1 more source
Nonmetastatic nasopharyngeal carcinoma: in search of safer therapies. [PDF]
The Lancet Regional Health-Americas.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Chemoradiotherapy improves NPC outcomes
Nature Reviews Clinical Oncology, 2020exaly +3 more sources
Nasopharyngeal Carcinoma (NPC)
1972Publisher Summary This chapter reviews the etiology of nasopharyngeal carcinoma (NPC) that has recently attracted worldwide interest because a high titer of antibodies to Epstein-Barr virus (EBV), which is suspected to have oncogenic properties, have been found with unusual frequency among patients with this neoplasm compared with the controls from ...
openaire +2 more sources

